Funding for this research was provided by:
Lynn Sage Cancer Research Foundation
Received: 26 March 2019
Accepted: 14 November 2019
First Online: 4 December 2019
Ethics approval and consent to participate
: Informed consent was waived per the IRB.
: Consent for publication is covered under the OncoSET Registry (NUDB 16Z01) for inclusion of the case vignette.
: Andrew Davis Travel expenses: Menarini Silicon Biosystems. Lorenzo Gerratana Travel expenses: Menarini Silicon Biosystems. Massimo Cristofanilli Honoraria: Pfizer, Merus, Novartis, CytoDyn. All other authors declare that they have no competing interests.